A patient who has been prescribed pyridostigmine for myasthenia gravis presents with excessive sweating vomiting, and bradycardia. Which of the following nursing actions should be prioritized to address these symptoms suspected to be from a cholinergic crisis?

Rationale: A. While fluid replacement and vital sign monitoring are important supportive measures, they do not reverse the life-threatening muscarinic and nicotinic effects of a cholinergic crisis. Solely providing fluids is insufficient for symptom management. B. Excessive sweating, vomiting, and bradycardia in a patient taking pyridostigmine indicate cholinergic crisis due to excessive acetylcholine. Atropine, an anticholinergic medication, blocks muscarinic effects, alleviating symptoms such as bradycardia, excessive salivation, and gastrointestinal hyperactivity. This is the priority intervention to prevent further complications and stabilize the patient. C. Increasing the dosage would worsen a cholinergic crisis, as the symptoms are caused by overstimulation of acetylcholine receptors, not by insufficient medication. This action is contraindicated and dangerous. D. Neurological assessment is important for ongoing monitoring, but it is not the priority intervention. Immediate treatment with atropine takes precedence to prevent deterioration such as severe bradycardia, respiratory compromise, or further muscarinic effects.